Growing Market Presence Strive Health has expanded its footprint across 50 states, serving over 145,000 patients with CKD and ESKD, indicating a substantial nationwide opportunity to scale partnerships with payors and healthcare providers engaged in kidney care.

Strong Funding & Investment With recent series D funding of 550 million dollars and a 250 million dollar debt financing, Strive has significant capital to invest in technological innovations and expand its care delivery capabilities, opening avenues for collaboration on large-scale healthcare projects.

Technological Leadership Utilizing advanced AI-driven care interventions and a certified platform, CareMultiplier, Strive offers a compelling value proposition to payors and providers seeking innovation-driven, efficient kidney care solutions that align with evolving value-based payment models.

Recognition & Awards Consistently recognized as a top employer and promising healthtech company, Strive’s reputable market positioning enhances its appeal to potential partners interested in innovative and well-regarded organizations within the healthcare ecosystem.

Strategic Acquisitions The recent acquisition of Semler Scientific positions Strive to strengthen its diagnostics and patient monitoring offerings, presenting an opportunity to collaborate on integrated solutions that enhance patient management and outcomes.